Appointment booking for Dr. Keith Yamanishi, OD is currently not available.Dr. Keith Yamanishi, OD has not yet fully activated their profile on DiabetesIQ.
Dr. Keith Yamanishi, OD (he/him) is a Optometrist in Sacramento, CA with over 18 years of experience. What is your opinion of Dr. Keith Yamanishi, OD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Keith Yamanishi, OD has received over $2,440 which includes payments from the following companies:
$636.64 from Allergan Inc.
$366.31 from Sun Pharmaceutical Industries Inc.
$341.46 from Valeant Pharmaceuticals North America LLC
$274.47 from Bausch & Lomb, a division of Bausch Health US, LLC
$179.16 from Johnson & Johnson Vision Care, Inc.
$163.73 from Shire North American Group Inc
$119.96 from Aerie Pharmaceuticals, Inc.
$102.75 from TissueTech, Inc.
$94.43 from Alcon Laboratories Inc
$48.22 from Novartis Pharmaceuticals Corporation
$24.77 from Akorn Inc.
$21.49 from Kala Pharmaceuticals, Inc.
$20.65 from OPTOS, INC.
$14.16 from CooperVision Inc.
$11.91 from Sight Sciences, Inc.
$10.49 from Perrigo Company plc
$9.63 from Visioneering Technologies, Inc.
Payments received by Dr. Keith Yamanishi, OD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!